ZA976655B - Benzimidazole, benzoxazole and benzothiazole compounds, process for preparing them and pharmaceutical compositions containing them. - Google Patents

Benzimidazole, benzoxazole and benzothiazole compounds, process for preparing them and pharmaceutical compositions containing them.

Info

Publication number
ZA976655B
ZA976655B ZA9706655A ZA976655A ZA976655B ZA 976655 B ZA976655 B ZA 976655B ZA 9706655 A ZA9706655 A ZA 9706655A ZA 976655 A ZA976655 A ZA 976655A ZA 976655 B ZA976655 B ZA 976655B
Authority
ZA
South Africa
Prior art keywords
optionally substituted
aryl
benzoxazole
benzimidazole
alkyl
Prior art date
Application number
ZA9706655A
Other languages
English (en)
Inventor
Guillaume De Nanteuil
Bernard Portevin
Jacqueline Bonnet
Armel Fradin
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of ZA976655B publication Critical patent/ZA976655B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/10—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA9706655A 1996-07-26 1997-07-25 Benzimidazole, benzoxazole and benzothiazole compounds, process for preparing them and pharmaceutical compositions containing them. ZA976655B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9609416A FR2751649B1 (fr) 1996-07-26 1996-07-26 Nouveaux derives de benzimidazole, de benzoxazole et de benzothiazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
ZA976655B true ZA976655B (en) 1998-02-10

Family

ID=9494506

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9706655A ZA976655B (en) 1996-07-26 1997-07-25 Benzimidazole, benzoxazole and benzothiazole compounds, process for preparing them and pharmaceutical compositions containing them.

Country Status (19)

Country Link
US (1) US5972968A (no)
EP (1) EP0820990B1 (no)
JP (1) JPH1067753A (no)
CN (1) CN1090620C (no)
AT (1) ATE198744T1 (no)
AU (1) AU715751B2 (no)
BR (1) BR9704076A (no)
CA (1) CA2211444C (no)
DE (1) DE69703915T2 (no)
DK (1) DK0820990T3 (no)
ES (1) ES2155660T3 (no)
FR (1) FR2751649B1 (no)
GR (1) GR3035434T3 (no)
HU (1) HUP9701297A1 (no)
NO (1) NO308602B1 (no)
NZ (1) NZ328431A (no)
PL (1) PL321336A1 (no)
PT (1) PT820990E (no)
ZA (1) ZA976655B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9602029D0 (en) * 1996-02-01 1996-04-03 Fujisawa Pharmaceutical Co New heterocyclic compounds
FR2766822B1 (fr) * 1997-07-30 2001-02-23 Adir Nouveaux derives de benzimidazole, de benzoxazole et de benzothiazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6248770B1 (en) * 1998-07-09 2001-06-19 Boehringer Ingelheim Pharma Kg Benzimidazoles having antithrombotic activity
DE69823240T2 (de) * 1998-10-23 2005-04-28 Toray Industries, Inc. Immunmodulierende arzneimittelzusammenstellung
US6451832B2 (en) 1999-12-23 2002-09-17 Boehringer Ingelheim Pharma Kg Benzimidazoles with antithrombotic activity
EP1253921A4 (en) 2000-01-28 2004-10-13 Merck & Co Inc TREATMENT AND PROPHYLAXIS OF PROSTATE CANCER WITH COX-2 SELECTIVE INHIBITORS
US6660858B2 (en) 2001-03-28 2003-12-09 Lion Bioscience Ag 2-aminobenzoxazole derivatives and combinatorial libraries thereof
BRPI0517925A (pt) * 2004-11-02 2008-10-21 Pfizer derivados de sulfonil benzimidazol
PE20070427A1 (es) * 2005-08-30 2007-04-21 Novartis Ag Compuestos derivados de benzimidazoles sustituidos como inhibidores de tirosina quinasas
FR2891273B1 (fr) * 2005-09-27 2007-11-23 Aventis Pharma Sa NOUVEAUX DERIVES BENZIMIDAZOLES ET BENZOTHIAZOLES, LEUR PREPARATION ET LEUR UTILISATION PHARMACEUTIQUE NOTAMMENT COMME INHIBITEURS DE CMet
US8653063B2 (en) * 2009-01-22 2014-02-18 Raqualia Pharma Inc. N-substituted saturated heterocyclic sulfone compounds with CB2 receptor agonistic activity
JPWO2010101164A1 (ja) 2009-03-05 2012-09-10 第一三共株式会社 ピリジン誘導体
JP2013510178A (ja) 2009-11-06 2013-03-21 ヴァンダービルト ユニバーシティー ｍＧｌｕＲ４アロステリック増強剤としてのアリールおよびヘテロアリールスルホン、組成物、および神経機能不全を治療する方法
TW201534597A (zh) 2013-06-20 2015-09-16 Ab Science 作為選擇性蛋白質激酶抑制劑之苯并咪唑衍生物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2290430A1 (fr) * 1974-11-06 1976-06-04 Aries Robert Nouveau mode de synthese d'esters carbamiques derives du benzimidazole
LU75684A1 (no) * 1976-08-27 1978-04-13
DE3067431D1 (en) * 1979-07-20 1984-05-17 Ciba Geigy Ag Coumarine compounds, processes for their manufacture as well as the intermediate products used perse and their utilisation for the dyeing or printing of textiles
GR78209B (no) * 1982-04-15 1984-09-26 May & Baker Ltd
US4430502A (en) * 1982-08-13 1984-02-07 The Upjohn Company Pyridinyl substituted benzimidazoles and quinoxalines
NZ221729A (en) * 1986-09-15 1989-07-27 Janssen Pharmaceutica Nv Imidazolyl methyl-substituted benzimidazole derivatives and pharmaceutical compositions
IT1222412B (it) * 1987-07-31 1990-09-05 Chiesi Farma Spa Tiometil e sulfinil metil derivati ad azione antisecretiva acida gastrica,loro procedimento di preparazione e composizioni farmaceutiche che li contengono
JP2869561B2 (ja) * 1989-05-22 1999-03-10 大塚製薬株式会社 血小板粘着抑制剤
JPH06759B2 (ja) * 1989-09-22 1994-01-05 ファイザー製薬株式会社 新規なベンゾイミダゾール化合物
IE910278A1 (en) * 1990-02-16 1991-08-28 Ici Plc Heterocyclic compounds
JPH08294229A (ja) * 1995-04-20 1996-11-05 Nec Corp 半導体集積回路装置
JPH09169729A (ja) * 1995-12-19 1997-06-30 Green Cross Corp:The 非ペプチド型インターロイキン８拮抗剤
JP3243733B2 (ja) * 1996-08-07 2002-01-07 雪印乳業株式会社 新規イソキノリン誘導体
JP2007024865A (ja) * 2005-06-17 2007-02-01 Renesas Technology Corp 半導体装置
KR100861371B1 (ko) * 2007-06-25 2008-10-01 주식회사 하이닉스반도체 온도센서 및 이를 이용한 반도체 메모리 장치
JP2009058438A (ja) * 2007-08-31 2009-03-19 Toshiba Corp 温度検出回路
JP5888009B2 (ja) * 2012-03-08 2016-03-16 株式会社豊田中央研究所 温度センサ回路

Also Published As

Publication number Publication date
AU715751B2 (en) 2000-02-10
CN1090620C (zh) 2002-09-11
DK0820990T3 (da) 2001-05-07
NZ328431A (en) 1997-12-19
CA2211444C (fr) 2002-07-09
JPH1067753A (ja) 1998-03-10
EP0820990A2 (fr) 1998-01-28
ATE198744T1 (de) 2001-02-15
PL321336A1 (en) 1998-02-02
CA2211444A1 (fr) 1998-01-26
GR3035434T3 (en) 2001-05-31
EP0820990B1 (fr) 2001-01-17
FR2751649B1 (fr) 1998-08-28
HUP9701297A1 (hu) 1999-09-28
DE69703915T2 (de) 2001-08-02
EP0820990A3 (fr) 1998-07-29
ES2155660T3 (es) 2001-05-16
NO973443L (no) 1998-01-27
NO973443D0 (no) 1997-07-25
HU9701297D0 (en) 1997-09-29
US5972968A (en) 1999-10-26
BR9704076A (pt) 1999-05-11
DE69703915D1 (de) 2001-02-22
PT820990E (pt) 2001-06-29
CN1174192A (zh) 1998-02-25
AU3017297A (en) 1998-02-05
NO308602B1 (no) 2000-10-02
FR2751649A1 (fr) 1998-01-30

Similar Documents

Publication Publication Date Title
HU9701297D0 (en) New benzimidazole benzoxazole and benzothiazole compounds, process for preparing them and pharmaceutical compositions containing them
ZA911403B (en) Derivatives having a naphthalene structure,process for preparing these and pharmaceutical compositions containing them
DE3775882D1 (de) Substituierte 6-fluor-4-oxo-1,4-dihydrochinolin-3-carbonsaeuren ; deren derivate; diese verbindung enthaltende pharmazeutische zubereitungen und verfahren zur herstellung dieser verbindungen.
GR3025268T3 (en) Substituted aminophosphonate derivatives, process for their preparation and pharmaceutical compositions containing them
HUT59693A (en) Process for producing morpholinyl derivatives of doxorubicin and pharmaceutical compositions containing them
PT91607A (pt) Process for the preparation of substituted beta-diketones and of pharmaceutical compositions containing them
HUT73973A (en) Substituted benzol-sulfonyl-ureas and thioureas, process for producing them, pharmaceutical or diagnostical use of them and pharmaceutical compositions containing them
FR2760014B1 (fr) Nouveaux composes de 2-amino indane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ZA875727B (en) 1,4-dihydropyridine derivatives,the process for preparing them and the pharmaceutical compositions which contain them
FR2713644B1 (fr) Nouveaux analogues de l'éburnane, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
ZA997707B (en) 1,2-dithiolane compounds, a process for their preparation and pharmaceutical compositions containing them.
FI844186A0 (fi) Bis(substituerad metyl) -metylisokinolinderivat och foerfarande foer framstaellning daerav.
SE8701524D0 (sv) Nya sulfonamider och deras framstellningsforfarande
DK0999212T3 (da) Antibaktierielle furopyridiner